Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis

What's known on the subject? and What does the study add? Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increas...

Full description

Saved in:
Bibliographic Details
Published inBJU international Vol. 111; no. 4; pp. 622 - 627
Main Authors Arrabal‐Polo, Miguel Angel, Arrabal‐Martin, Miguel, Arias‐Santiago, Salvador, Garrido‐Gomez, Juan, Poyatos‐Andujar, Antonio, Zuluaga‐Gomez, Armando
Format Journal Article
LanguageEnglish
Published Oxford Wiley-Blackwell 01.04.2013
Subjects
Online AccessGet full text
ISSN1464-4096
1464-410X
1464-410X
DOI10.1111/j.1464-410X.2012.11292.x

Cover

Loading…
Abstract What's known on the subject? and What does the study add? Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β‐crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity. Objective To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis. Material and Methods A cross‐sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25–60 years without calcium renal lithiasis; Group B: 59 patients aged 25–60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients’ urine and the relationship of these two factors to lithiasic activity were analysed and compared. Results In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T‐score values of patients. Conclusions The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β‐crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.
AbstractList What's known on the subject? and What does the study add? Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β‐crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity. Objective To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis. Material and Methods A cross‐sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25–60 years without calcium renal lithiasis; Group B: 59 patients aged 25–60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients’ urine and the relationship of these two factors to lithiasic activity were analysed and compared. Results In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T‐score values of patients. Conclusions The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β‐crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.UNLABELLEDDifferent studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity.To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.OBJECTIVETo analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis.A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared.MATERIAL AND METHODSA cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared.In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients.RESULTSIn Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients.The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.CONCLUSIONSThe patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases. The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased β-crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity. To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis. A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted. The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis. The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared. In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02). The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005). The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%). After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients. The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density. The calcium : citrate ratio, which is linearly related to the bone resorption marker β-crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis result in an increase in bone resorption and lower urinary citrate levels. Increasing the intake of citrate in these patients can reduce the lithogenic risk and improve bone mineral density (BMD), contributing to control of both diseases.The study shows the importance of citrate in patients with calcium stones and BMD loss. The deficit in citrate excretion is associated with a decrease in bone mineralization and increased beta -crosslaps. A calcium : citrate ratio >0.25 in patients with calcium stones and loss of mineral density may predict severe lithogenic activity. To analyse the importance of urinary citrate and the urinary calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis compared with a control group of patients without lithiasis. A cross-sectional study of 115 patients in eastern Andalusia, Spain was conducted.The patients were divided into two groups: Group A: 56 patients aged 25-60 years without calcium renal lithiasis; Group B: 59 patients aged 25-60 years, presenting with calcium renal lithiasis and severe lithogenesis.The citrate levels and the calcium : citrate ratio in the patients' urine and the relationship of these two factors to lithiasic activity were analysed and compared. In Group B, 32.2% of the patients presented with hypocitraturia, compared with 14.3% of the patients in Group A (P = 0.02).The urinary citrate levels were lower in Group B than in Group A (P = 0.001) and the calcium : citrate ratio was higher in Group B than in Group A (P = 0.005).The results suggest that a patient urinary calcium : citrate ratio > 0.25 indicates severe lithogenesis (with a sensitivity of 89% and a specificity of 57%).After linear regression analysis, we found that the urinary citrate level is an independent factor associated with the changes in bone densitometry T-score values of patients. The patients with severe lithogenesis presented with hypocitraturia, which was associated with lower bone mineral density.The calcium : citrate ratio, which is linearly related to the bone resorption marker beta -crosslaps, could be useful in evaluating the risk of severe lithogenesis when this ratio is >0.25.
Author Arrabal‐Polo, Miguel Angel
Arrabal‐Martin, Miguel
Poyatos‐Andujar, Antonio
Garrido‐Gomez, Juan
Arias‐Santiago, Salvador
Zuluaga‐Gomez, Armando
Author_xml – sequence: 1
  givenname: Miguel Angel
  surname: Arrabal‐Polo
  fullname: Arrabal‐Polo, Miguel Angel
  organization: San Cecilio University Hospital
– sequence: 2
  givenname: Miguel
  surname: Arrabal‐Martin
  fullname: Arrabal‐Martin, Miguel
  organization: San Cecilio University Hospital
– sequence: 3
  givenname: Salvador
  surname: Arias‐Santiago
  fullname: Arias‐Santiago, Salvador
  organization: University of Granada
– sequence: 4
  givenname: Juan
  surname: Garrido‐Gomez
  fullname: Garrido‐Gomez, Juan
  organization: San Cecilio University Hospital
– sequence: 5
  givenname: Antonio
  surname: Poyatos‐Andujar
  fullname: Poyatos‐Andujar, Antonio
  organization: San Cecilio University Hospital
– sequence: 6
  givenname: Armando
  surname: Zuluaga‐Gomez
  fullname: Zuluaga‐Gomez, Armando
  organization: San Cecilio University Hospital
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27220563$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22757744$$D View this record in MEDLINE/PubMed
BookMark eNqNkctu1DAUhi1URC_wCsibSmxm8C3xhAUSVG0pqsSGSuwsxzmmHiXOYGfoZdUtr8mT9GQ6oRKrsWT76Pd3jqX_PyR7sY9ACOVsznG9X865KtVMcfZjLhgXqIpKzG9fkIN_D3tTzapynxzmvGQMhbJ4RfaF0IXWSh2Q-4tu1afBRge099SFIdkBqI0NHa6BOtu6sO7-Pvz5gHt6xSP0NES6wgLikOlNGK4nmCaItqUtSsHmkDfDMvyGBBux_wkRUH9NXnrbZnizvY_I1dnp95Mvs8tv5xcnny5nTkkpZqJpeO2aCqxwleeFU3qhZKG4Vwg0lWS29hq85o3z0NhSi9paVVQ1VzX2yCPy7mnuKvW_1pAH04XsoG1thH6dDZeFEAtZFXoHVCi5UEILRN9u0XXdQWNWKXQ23ZnJWgSOt4DN6IxP6HHIz5wWghWlRO7jE-dSn3MCb9Dm0eCIZofWcGbGzM3SjHGaMVozZm42mZtbHLD4b8D0xw6t279vQgt3O_eZz1-vNqV8BJB2x0Y
CitedBy_id crossref_primary_10_1007_s00467_020_04754_6
crossref_primary_10_1007_s00467_020_04693_2
crossref_primary_10_1002_14651858_CD011252_pub2
crossref_primary_10_1155_2017_5391832
crossref_primary_10_1007_s11255_016_1361_5
crossref_primary_10_1039_C5AN00033E
crossref_primary_10_1186_s12894_018_0430_8
crossref_primary_10_1186_s12894_020_00749_5
crossref_primary_10_1097_MOU_0000000000000111
crossref_primary_10_1371_journal_pone_0177329
crossref_primary_10_1007_s11255_023_03662_6
crossref_primary_10_1002_14651858_CD011252
crossref_primary_10_1016_j_urology_2015_01_019
crossref_primary_10_1016_j_acuro_2012_10_003
crossref_primary_10_1039_C5CC08759G
crossref_primary_10_1111_jpc_15770
crossref_primary_10_1007_s11255_015_0918_z
Cites_doi 10.2741/1119
10.1590/S1677-55382005000100006
10.1007/s11255-009-9599-9
10.1159/000189140
10.1016/j.ucl.2007.04.007
10.1016/j.ucl.2007.04.009
10.1002/jbmr.5650091004
10.1016/S0022-5347(05)67487-3
10.1111/j.1464-410X.2011.10167.x
10.5414/CNP63188
10.1159/000473606
10.1016/j.urology.2009.09.084
10.1016/j.urology.2010.01.036
10.1016/S0022-5347(05)64825-2
ContentType Journal Article
Copyright 2012 BJU International
2014 INIST-CNRS
2012 BJU International.
Copyright_xml – notice: 2012 BJU International
– notice: 2014 INIST-CNRS
– notice: 2012 BJU International.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7QP
DOI 10.1111/j.1464-410X.2012.11292.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Calcium & Calcified Tissue Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Calcium & Calcified Tissue Abstracts
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Calcium & Calcified Tissue Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-410X
EndPage 627
ExternalDocumentID 22757744
27220563
10_1111_j_1464_410X_2012_11292_x
BJU11292
Genre article
Journal Article
Comparative Study
GeographicLocations Spain
GeographicLocations_xml – name: Spain
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZGI
ZXP
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
7QP
ID FETCH-LOGICAL-c4332-2dd1bcd9ea2c9f15c47843541f4c43d930abf7ef71dcfeda672baa459b14ba2c3
IEDL.DBID DR2
ISSN 1464-4096
1464-410X
IngestDate Fri Jul 11 16:39:23 EDT 2025
Fri Jul 11 01:49:47 EDT 2025
Thu Apr 03 07:07:08 EDT 2025
Wed Apr 02 07:15:04 EDT 2025
Thu Apr 24 22:54:26 EDT 2025
Tue Jul 01 03:49:58 EDT 2025
Wed Jan 22 16:52:39 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Kidney disease
Human
Urine
Nephrology
Urinary system disease
Calciuria
Calcium
lithogenic activity
Citrate
Inorganic element
urinary calcium: citrate ratio
Biological activity
Urology
Urinary stone
Osteoarticular system
urinary citrate
Renal lithiasis
Ratio
Bone
Severe
Language English
License CC BY 4.0
2012 BJU International.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4332-2dd1bcd9ea2c9f15c47843541f4c43d930abf7ef71dcfeda672baa459b14ba2c3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 22757744
PQID 1324384272
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1352283957
proquest_miscellaneous_1324384272
pubmed_primary_22757744
pascalfrancis_primary_27220563
crossref_citationtrail_10_1111_j_1464_410X_2012_11292_x
crossref_primary_10_1111_j_1464_410X_2012_11292_x
wiley_primary_10_1111_j_1464_410X_2012_11292_x_BJU11292
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2013
PublicationDateYYYYMMDD 2013-04-01
PublicationDate_xml – month: 04
  year: 2013
  text: April 2013
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle BJU international
PublicationTitleAlternate BJU Int
PublicationYear 2013
Publisher Wiley-Blackwell
Publisher_xml – name: Wiley-Blackwell
References 1994; 9
2010; 76
2010; 42
1991; 19
2011; 108
1991; 58
2002; 168
2003; 8
2006; 59
2005; 63
2005; 31
2011; 33
2003; 16
1996; 73
2000; 164
2007; 60
1998; 50
2007; 34
2005; 55
1990; 83
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
Audran M (e_1_2_7_21_1) 1991; 58
e_1_2_7_3_1
Simic‐Ogrizovic S (e_1_2_7_7_1) 2007; 60
e_1_2_7_9_1
e_1_2_7_8_1
Mithani S (e_1_2_7_12_1) 2005; 55
e_1_2_7_18_1
e_1_2_7_17_1
Arrabal Martin M (e_1_2_7_2_1) 2006; 59
Batista Peres LA (e_1_2_7_14_1) 2011; 33
e_1_2_7_13_1
e_1_2_7_23_1
e_1_2_7_11_1
e_1_2_7_22_1
e_1_2_7_10_1
Giannini S (e_1_2_7_19_1) 1998; 50
Caudarella R (e_1_2_7_20_1) 2003; 16
Höbarth K (e_1_2_7_16_1) 1991; 19
Hofbauer J (e_1_2_7_15_1) 1990; 83
22757770 - BJU Int. 2013 Apr;111(4):529-30
References_xml – volume: 60
  start-page: 117
  year: 2007
  end-page: 120
  article-title: The most important factor for active urinary stone formation in patients with urolithiasis
  publication-title: Med Pregl
– volume: 31
  start-page: 29
  year: 2005
  end-page: 33
  article-title: Metabolic assessment in patients with urinary lithiasis
  publication-title: Int Braz J Urol
– volume: 33
  start-page: 34
  year: 2011
  end-page: 38
  article-title: Nephrolithiasis in pediatric patients: metabolic and anatomical investigation
  publication-title: J Bras Nefrol
– volume: 59
  start-page: 583
  year: 2006
  end-page: 594
  article-title: Study of the physical‐chemical factors in patients with renal lithiasis
  publication-title: Arch Esp Urol
– volume: 164
  start-page: 162
  year: 2000
  end-page: 165
  article-title: A study of the etiology of idiopathic calcium urolithiasis in children: hypocitraturia is the most important risk factor
  publication-title: J Urol
– volume: 63
  start-page: 188
  year: 2005
  end-page: 192
  article-title: Risk factors determining active urinary stone formation in patients with urolithiasis
  publication-title: Clin Nephrol
– volume: 76
  start-page: 242
  year: 2010
  end-page: 246
  article-title: The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate
  publication-title: Urology
– volume: 58
  start-page: 747
  year: 1991
  end-page: 750
  article-title: Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X‐ray computed tomography and histomorphometry
  publication-title: Rev Rhum Mal Osteoartic
– volume: 9
  start-page: 1525
  year: 1994
  end-page: 1532
  article-title: Low bone mass in idiopathic renal stone formers: magnitude and significance
  publication-title: J Bone Miner Res
– volume: 42
  start-page: 127
  year: 2010
  end-page: 131
  article-title: Metabolic abnormalities in patients with nephrolithiasis: comparison of first‐episode with recurrent cases in Southern Iran
  publication-title: Int Urol Nephrol
– volume: 16
  start-page: 260
  year: 2003
  end-page: 266
  article-title: Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors
  publication-title: J Nephrol
– volume: 108
  start-page: 1903
  year: 2011
  end-page: 1908
  article-title: Mineral density and bone remodelling markers in patients with calcium lithiasis
  publication-title: BJU Int
– volume: 83
  start-page: 597
  year: 1990
  end-page: 602
  article-title: The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi
  publication-title: Z Urol Nephrol
– volume: 76
  start-page: 238
  year: 2010
  end-page: 241
  article-title: Metabolic evaluation in stone disease metabolic differences between the pediatric and adult patients with stone disease
  publication-title: Urology
– volume: 34
  start-page: 323
  year: 2007
  end-page: 334
  article-title: Pathophysiology and management of calcium stones
  publication-title: Urol Clin North Am
– volume: 168
  start-page: 31
  year: 2002
  end-page: 34
  article-title: Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis
  publication-title: J Urol
– volume: 73
  start-page: 557
  year: 1996
  end-page: 560
  article-title: Bone mineral density in patients with hypercalciuric nephrolithiasis
  publication-title: Nephron
– volume: 50
  start-page: 94
  year: 1998
  end-page: 100
  article-title: Bone density and skeletal metabolism are altered in idiopathic hypercalciuria
  publication-title: Clin Nephrol
– volume: 55
  start-page: 371
  year: 2005
  end-page: 373
  article-title: Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls
  publication-title: J Pak Med Assoc
– volume: 8
  start-page: s1084
  year: 2003
  end-page: 1086
  article-title: Citrate and mineral metabolism: kidney stones and bone disease
  publication-title: Front Biosci
– volume: 34
  start-page: 315
  year: 2007
  end-page: 322
  article-title: Evaluation of the recurrent stone former
  publication-title: Urol Clin North Am
– volume: 19
  start-page: 165
  year: 1991
  end-page: 168
  article-title: Value of routine citrate analysis and calcium/citrate ration in calcium urolithiasis
  publication-title: Eur Urol
– ident: e_1_2_7_18_1
  doi: 10.2741/1119
– ident: e_1_2_7_3_1
  doi: 10.1590/S1677-55382005000100006
– volume: 83
  start-page: 597
  year: 1990
  ident: e_1_2_7_15_1
  article-title: The significance of citrate excretion and calcium/citrate quotients in urine in patients with calcium calculi
  publication-title: Z Urol Nephrol
– ident: e_1_2_7_11_1
  doi: 10.1007/s11255-009-9599-9
– ident: e_1_2_7_22_1
  doi: 10.1159/000189140
– volume: 58
  start-page: 747
  year: 1991
  ident: e_1_2_7_21_1
  article-title: Bone density in idiopathic hypercalciuria in men. Study by dual photon absorptiometry, X‐ray computed tomography and histomorphometry
  publication-title: Rev Rhum Mal Osteoartic
– ident: e_1_2_7_8_1
  doi: 10.1016/j.ucl.2007.04.007
– ident: e_1_2_7_10_1
  doi: 10.1016/j.ucl.2007.04.009
– ident: e_1_2_7_23_1
  doi: 10.1002/jbmr.5650091004
– ident: e_1_2_7_6_1
  doi: 10.1016/S0022-5347(05)67487-3
– volume: 55
  start-page: 371
  year: 2005
  ident: e_1_2_7_12_1
  article-title: Comparison of 24 hours urinary citrate levels in urolithiasis patients and healthy controls
  publication-title: J Pak Med Assoc
– volume: 59
  start-page: 583
  year: 2006
  ident: e_1_2_7_2_1
  article-title: Study of the physical‐chemical factors in patients with renal lithiasis
  publication-title: Arch Esp Urol
– volume: 16
  start-page: 260
  year: 2003
  ident: e_1_2_7_20_1
  article-title: Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors
  publication-title: J Nephrol
– ident: e_1_2_7_9_1
  doi: 10.1111/j.1464-410X.2011.10167.x
– volume: 33
  start-page: 34
  year: 2011
  ident: e_1_2_7_14_1
  article-title: Nephrolithiasis in pediatric patients: metabolic and anatomical investigation
  publication-title: J Bras Nefrol
– volume: 60
  start-page: 117
  year: 2007
  ident: e_1_2_7_7_1
  article-title: The most important factor for active urinary stone formation in patients with urolithiasis
  publication-title: Med Pregl
– ident: e_1_2_7_4_1
  doi: 10.5414/CNP63188
– volume: 19
  start-page: 165
  year: 1991
  ident: e_1_2_7_16_1
  article-title: Value of routine citrate analysis and calcium/citrate ration in calcium urolithiasis
  publication-title: Eur Urol
  doi: 10.1159/000473606
– volume: 50
  start-page: 94
  year: 1998
  ident: e_1_2_7_19_1
  article-title: Bone density and skeletal metabolism are altered in idiopathic hypercalciuria
  publication-title: Clin Nephrol
– ident: e_1_2_7_13_1
  doi: 10.1016/j.urology.2009.09.084
– ident: e_1_2_7_5_1
  doi: 10.1016/j.urology.2010.01.036
– ident: e_1_2_7_17_1
  doi: 10.1016/S0022-5347(05)64825-2
– reference: 22757770 - BJU Int. 2013 Apr;111(4):529-30
SSID ssj0014665
Score 2.1757395
Snippet What's known on the subject? and What does the study add? Different studies have shown the importance of citrate in the formation of calcium stones. It has...
Different studies have shown the importance of citrate in the formation of calcium stones. It has further been shown that the states of metabolic acidosis...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 622
SubjectTerms Adult
Biological and medical sciences
Biomarkers - analysis
bone
Bone Density
Calcium - metabolism
Calcium - urine
Calculi - chemistry
Citric Acid - metabolism
Citric Acid - urine
Confidence Intervals
Creatinine - urine
Cross-Sectional Studies
Decalcification, Pathologic - physiopathology
Female
Humans
Incidence
Linear Models
lithogenic activity
Logistic Models
Male
Medical sciences
Middle Aged
Multivariate Analysis
Nephrolithiasis - diagnosis
Nephrolithiasis - epidemiology
Nephrolithiasis - urine
Nephrology. Urinary tract diseases
Odds Ratio
Predictive Value of Tests
Prognosis
Risk Assessment
ROC Curve
Severity of Illness Index
Spain
Urinalysis
urinary calcium : citrate ratio
urinary citrate
Urinary lithiasis
Title Importance of citrate and the calcium : citrate ratio in patients with calcium renal lithiasis and severe lithogenesis
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1464-410X.2012.11292.x
https://www.ncbi.nlm.nih.gov/pubmed/22757744
https://www.proquest.com/docview/1324384272
https://www.proquest.com/docview/1352283957
Volume 111
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh1Iobfrepg0q9OpFkmV5nVtbGtJAeihd2JvQszVJvGG9CyWnXvs380s6I9tbHEIJpQeDsWcsS56RPsmjbwh56xSP3Fchswa8SSpmM8ucyBSDDjkyz4TDdciTz-poLo8XxaKPf8K9MB0_xHbBDT0j9dfo4Ma2151cZpKzBUZoCdwMU4kp4kkM3UJ89GXLJAWiKatkpwKwfRzUc-ODRiPV_QvTQqPFLtvFTXB0jG7T8HT4kJwOFeuiUk6nm7WdustrnI__p-a75EGPYum7zuwekTuheUzunvT_6Z-Qy0_nCdeDRdFlpK5OHLjUNJ4C4KRQRVdvzq9-_jqAY7ibbJHWDe25XluKi8SDMF0FLBJmDd9r09ZtehgM62EV0sXlN-y16_YpmR9-_PrhKOuzPGQOudMy4T23DszFCFdFXjhZzgDDSR4lCPgqZ8bGMsSSexeDN6oU1hhZVJZLCzr5M7LTLJvwglCroP-RyisLyj6PMw_zXxatZ8z4WBQTUg5fVLueAh0zcZzp0VRIamxajU2rU9PqHxPCt5oXHQ3ILXT2R0azVRQl7m5W-YS8GaxIg1PjnxrThOWm1Rxgbj6TIPg3mQKpi6qinJDnnQn-KUGUBeB6CRVOhnTrd9bvj-fp9OU_a-6ReyKlDMHopldkZ73ahNcA3NZ2P7nkb9fgN4Y
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yggri_TJe1gi-dkjStJ36puIyu-7sg-zAvIVctbjbWaYzIPvkq3_TX-I5aTvSZZFFfCiU9pykSc9Jvty-Q8gbm_PAXekTo8GbZM5MYpgVSc6gQQ7MMWFxHnJ2lE_n8mCRLbpwQHgWpuWH2E64oWfE9hodHCekL3q5TCRnC9yiJfA0TCnGACivY4DvOL76vOWSAtkYV7LVAeA-3NZzaUqDvur2mW6g2kIb7-IyQDrEt7GD2rtLTvqitftSvo03azO25xdYH_9T2e-ROx2Qpe9ay7tPrvn6Abkx65bqH5Lz_dMI7cGo6DJQW0UaXKprRwFzUiijrTanv378fAtX_zaaI61q2tG9NhTniXthuvKYJQwcvla6qZqYGPTsfuXjw-UXbLir5hGZ7308_jBNukAPiUX6tEQ4x40Fi9HCloFnVhYTgHGSBwkCrkyZNqHwoeDOBu90XgijtcxKw6UBnfQx2amXtX9KqMmhCZK5yw0ouzRMHAyBWTCOMe1Clo1I0f9SZTsWdAzGcaIGoyGpsGoVVq2KVau-jwjfap61TCBX0NkdWM1WURR4wDlPR-R1b0YK_BoXa3Ttl5tGcUC66USC4N9kMmQvKrNiRJ60NvgnB1FkAO0lFDha0pW_Wb0_mMfbZ_-s-YrcnB7PDtXh_tGn5-SWiBFEcLPTC7KzXm38S8Bxa7Mb_fM3PJI7oQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlgVAo6bvdpk1V6NWLJMvyure26ZKkTSilC3sTeqYmjXdZ70LIKdf-zf6SjGR7i0MoofRgMPaMZcnfSJ_k0QxCb42gntrCJVqBNXFBdKKJYYkg0CF7YgkzYR3y6FjsT_jhNJu2_k9hL0wTH2K94BYsI_bXwcDn1l83cp5wSqbBQ4uFzTAFGwKf3IQiRwHhe9_WoaRANqaVbHSAt_e9em58Um-oujdXNbSab9Jd3MRH-_Q2jk_j--i0q1njlnI6XC310FxcC_r4f6r-AG23NBa_b3D3EN1x1SO0ddT-qH-MLg7OIrEHSOGZx6aMQXCxqiwGxomhiqZcnf2-_PUOju5uBCMuK9wGe61xWCXuhPHChSJh2vCjVHVZx4fBuO4WLl6cnYRuu6yfoMn40_eP-0mb5iExIXhawqyl2gBeFDOFp5nh-QhIHKeeg4AtUqK0z53PqTXeWSVyppXiWaEp16CTPkUb1axyzxHWAjogLqzQoGxTP7IwASZeW0KU9Vk2QHn3RaVpY6CHVBw_ZW8uxGVoWhmaVsamlecDRNea8yYOyC10dnugWSuyPGxvFukAvelQJMGqw68aVbnZqpYUeG464iD4N5ksxC4qsnyAnjUQ_FMCyzMg9hwqHIF063eWHw4n8fTFP2u-Rltf98byy8Hx5x10l8X0IcHT6SXaWC5W7hWQuKXejdZ5BXHmOlk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+citrate+and+the+calcium%E2%80%89%3A%E2%80%89citrate+ratio+in+patients+with+calcium+renal+lithiasis+and+severe+lithogenesis&rft.jtitle=BJU+international&rft.au=Arrabal%E2%80%90Polo%2C+Miguel+Angel&rft.au=Arrabal%E2%80%90Martin%2C+Miguel&rft.au=Arias%E2%80%90Santiago%2C+Salvador&rft.au=Garrido%E2%80%90Gomez%2C+Juan&rft.date=2013-04-01&rft.issn=1464-4096&rft.eissn=1464-410X&rft.volume=111&rft.issue=4&rft.spage=622&rft.epage=627&rft_id=info:doi/10.1111%2Fj.1464-410X.2012.11292.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1464_410X_2012_11292_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon